JPRN-UMIN000018089已完成未知
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B region - Assessment of NS3, NS5A and NS5B amino acid mutations in genoytpe 2 HCV
Department of Gastroenterology & Hepatology, Saitama Medical University0 个研究点目标入组 40 人开始时间: 2015年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •the patients infected with HCV other than genotype 2
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
招募中
不适用
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000017703Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
招募中
不适用
Evaluation of the efficacy of sofosbuvir and velpatasvir in HCV-infected Japanese patients with decompensated cirrhosis: a prospective study in real life settings.decompensated cirrhotic patients with hepatitis C virusJPRN-UMIN000035711Toranomon Hospital100
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
已完成
不适用
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35
